The peripheral endocannabinoid system and its association with biomarkers of inflammation in untreated patients with multiple sclerosis.
Stefan GustavsenA OlssonA B OturaiK LinnetR ThomsenB S RasmussenC F JørgensenA R LangkildeP S SorensenF SellebjergH B SøndergaardPublished in: European journal of neurology (2023)
We found no alteration in the peripheral ECS between untreated patients with MS and HC. Furthermore, our results indicates that the ECS has a minor overall involvement in the early stage of MS on inflammatory markers and clinical parameters when compared with HCs.